Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;49(9):3919-21.
doi: 10.1128/AAC.49.9.3919-3921.2005.

Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi

Affiliations

Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi

Alisa P Alker et al. Antimicrob Agents Chemother. 2005 Sep.

Abstract

We conducted a prevalence study of mutations in Plasmodium falciparum that are associated with antifolate resistance in Blantyre, Malawi. The dihydrofolate reductase 164-Leu mutation, which confers resistance to both pyrimethamine and chlorproguanil, was found in 4.7% of the samples. Previously unreported mutations in dihydropteroate synthase were also found.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
The prevalence of mutant (black) and mixed (gray) genotypes in samples from pregnant women with malaria in Blanytre, Malawi. A mutant genotype is defined as encoding DHFR-51-Ile, DHFR-59-Arg, DHFR-108-Asn/Thr, DHFR-164-Leu, DHPS-437-Gly, DHPS-540-Glu, DHPS-581-Gly, and DHPS-613-Ser/Thr. The sample size is 89 for all codons except for the DHFR-59 (n = 90), DHPS-437 (n = 90), and DHFR-164 (n = 85) codons.

References

    1. Alker, A., V. Mwapasa, and S. R. Meshnick. 2004. Rapid real-time PCR genotyping of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 48:2924-2929. - PMC - PubMed
    1. Alloueche, A., W. Bailey, S. Barton, J. Bwika, P. Chimpeni, C. O. Falade, F. A. Fehintola, J. Horton, S. Jaffar, T. Kanyok, P. G. Kremsner, J. G. Kublin, T. Lang, M. A. Missinou, C. Mkandala, A. M. Odoula, Z. Premji, L. Robertson, A. Sowunmi, S. A. Ward, and P. A. Winstanley. 2004. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet 363:1843-1848. - PubMed
    1. Berens, N., B. Schwoebel, S. Jordan, V. Vanisaveth, R. Phetsouvanh, E. M. Christophel, S. Phompida, and T. Jelinek. 2003. Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR. Trop. Med. Int. Health 8:775-782. - PubMed
    1. Biswas, S., A. Escalante, S. Chaiyaroj, P. Angkasekwinai, and A. A. Lal. 2000. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Trop. Med. Int. Health 5:737-743. - PubMed
    1. Bwijo, B., A. Kaneko, M. Takechi, I. L. Zungu, Y. Moriyama, L. K. Lum, T. Tsukahara, T. Mita, N. Takahashi, Y. Bergqvist, A. Bjorkman, and T. Kobayakawa. 2003. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop. 85:363-373. - PubMed

Publication types

MeSH terms

LinkOut - more resources